Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marban

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Biophysical Journal|May 1, 1995
A mutation in the pore of the sodium channel alters gatingG F Tomaselli, N Chiamvimonvat, H B Nuss, et al.
Plos One|July 30, 2013
Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteasesRizwan Aslam, Céline Marban, Christian Corazzol, et al.
Journal of Pharmaceutical Sciences|April 4, 2021
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to BedsideKatharine Bray-French, Katharina Hartman, Guido Steiner, et al.
Peptides|July 8, 2015
Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injuryElisabetta Filice, Teresa Pasqua, Anna Maria Quintieri, et al.
Scientific Reports|March 4, 2017
Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sitesSylvain Fauquenoy, Gwenaëlle Robette, Anna Kula, et al.
Journal of the American College of Cardiology|June 12, 2010
Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndromeMarta Tomás, Carlo Napolitano, Luciana De Giuli, et al.
Scientific Reports|November 8, 2022
New definitions of human lymphoid and follicular cell entities in lymphatic tissue by machine learningPatrick Wagner, Nils Strodthoff, Patrick Wurzel, et al.
Journal of Immunotoxicology|March 4, 2020
Cross-company evaluation of the human lymphocyte activation assayMark Collinge, Patricia Schneider, Dingzhou Li, et al.
Frontiers in Immunology|September 12, 2024
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicityMichel Siegel, Anna-Lena Bolender, Axel Ducret, et al.
Oncogene|July 8, 2009
p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1T Cherrier, S Suzanne, L Redel, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Biophysical Journal|May 1, 1995
A mutation in the pore of the sodium channel alters gatingG F Tomaselli, N Chiamvimonvat, H B Nuss, et al.
Plos One|July 30, 2013
Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteasesRizwan Aslam, Céline Marban, Christian Corazzol, et al.
Journal of Pharmaceutical Sciences|April 4, 2021
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to BedsideKatharine Bray-French, Katharina Hartman, Guido Steiner, et al.
Peptides|July 8, 2015
Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injuryElisabetta Filice, Teresa Pasqua, Anna Maria Quintieri, et al.
Scientific Reports|March 4, 2017
Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sitesSylvain Fauquenoy, Gwenaëlle Robette, Anna Kula, et al.
Journal of the American College of Cardiology|June 12, 2010
Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndromeMarta Tomás, Carlo Napolitano, Luciana De Giuli, et al.
Scientific Reports|November 8, 2022
New definitions of human lymphoid and follicular cell entities in lymphatic tissue by machine learningPatrick Wagner, Nils Strodthoff, Patrick Wurzel, et al.
Journal of Immunotoxicology|March 4, 2020
Cross-company evaluation of the human lymphocyte activation assayMark Collinge, Patricia Schneider, Dingzhou Li, et al.
Frontiers in Immunology|September 12, 2024
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicityMichel Siegel, Anna-Lena Bolender, Axel Ducret, et al.
Oncogene|July 8, 2009
p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1T Cherrier, S Suzanne, L Redel, et al.
Pageof 23